Literature DB >> 1892745

Can we prevent breast cancer?

M Baum, Y Ziv, A A Colletta.   

Abstract

Entities:  

Keywords:  Behavior; Biology; Breast Cancer--prevention and control; Caloric Intake; Cancer; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Cytologic Effects; Developed Countries; Diseases; Drugs; Europe; Examinations And Diagnoses; Family Planning; Fertility Agents; Gestodene; Health; Lipids; Literature Review; Menopause; Neoplasms; Northern Europe; Nutrition; Oral Contraceptives; Physiology; Reproduction; Reproductive Control Agents; Screening; Surgery; Tamoxifen; Treatment; United Kingdom; User Compliance

Mesh：

Substances：

Year:  1991        PMID： 1892745      PMCID： PMC1977542          DOI： 10.1038/bjc.1991.276

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  24 in total

Review 1.  Tamoxifen: transition from the laboratory to clinical preventive chemosuppression.

Authors:  D C Tormey
Journal:  Cancer Invest       Date:  1988       Impact factor: 2.176

Review 2.  Chemosuppression of breast cancer with tamoxifen: laboratory evidence and future clinical investigations.

Authors:  V C Jordan
Journal:  Cancer Invest       Date:  1988       Impact factor: 2.176

3.  The prevention of breast cancer.

Authors:  J Cuzick; D Y Wang; R D Bulbrook
Journal:  Lancet       Date:  1986-01-11       Impact factor: 79.321

4.  Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme.

Authors:  T J Powles; C R Tillyer; A L Jones; S E Ashley; J Treleaven; J B Davey; J A McKinna
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

5.  The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer.

Authors:  A Gotfredsen; C Christiansen; T Palshof
Journal:  Cancer       Date:  1984-02-15       Impact factor: 6.860

Review 6.  Aspects of the rationale for the Women's Health Trial.

Authors:  R L Prentice; F Kakar; S Hursting; L Sheppard; R Klein; L H Kushi
Journal:  J Natl Cancer Inst       Date:  1988-08-03       Impact factor: 13.506

7.  Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.

Authors:  M M Gottardis; V C Jordan
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

8.  Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.

Authors:  C Coles; A M Thompson; P A Elder; B B Cohen; I M Mackenzie; G Cranston; U Chetty; J Mackay; M Macdonald; Y Nakamura
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

9.  Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats.

Authors:  T A Ratko; C J Detrisac; N M Dinger; C F Thomas; G J Kelloff; R C Moon
Journal:  Cancer Res       Date:  1989-08-15       Impact factor: 12.701

10.  The feasibility of testing experimentally the dietary fat-breast cancer hypothesis.

Authors:  N F Boyd; M Cousins; G Lockwood; D Tritchler
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640
View more
  2 in total

1.  Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries.

Authors:  M Quinn; E Allen
Journal:  BMJ       Date:  1995-11-25

2.  Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K.

Authors:  E Yefenof; I Gafanovitch; E Oron; M Bar; E Klein
Journal:  Cancer Immunol Immunother       Date:  1995-12       Impact factor: 6.968
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.